|
Re: resection of bc mets to liver prolongs survival in ER+ chemosensitive patients
Thank you so much for posting this! I have a tiny liver met (not confirmed, but doubled in size in 2 1/2 months), and I can't imagine why I wouldn't want to have it cut away. The liver regenerates, so what are the risks? Other than the usual risks with any surgery. I know they can't do anything until it is confirmed cancer, but if it is, I would love to either cyberknife it or resect it. This data is something I can use if I need to. I don't know why it would be more effective in ER+ vs. HER2+ though. Surgery is surgery isn't it?
__________________
March 2010: Diagnosed with Stage IIIC IDC with axillary, mammary and suplaclavicular node involvement. ER/PR -, HER2+++. 7cm tumor in right breast.
April 2010: Started neoadjuvent chemo. 4 DD A/C every 2 weeks, 4 DD Taxotere every 3 weeks with Herceptin weekly.
August 2010: Finished chemo!
August 20, 2010: PET/CT showed no cancer in any nodes, and only a little uptake to the breast.
September 9, 2010: Bilateral mastectomy with immediate reconstruction with implants and Alloderm.
September 16, 2010: Pathology report showed 18/51 positive axillary nodes, 3.2cm tumor. Granual sized cancer found in the fatty tissue between levels 1 and 2.
October 19, 2010: CT showed several spots on lungs and 1 spot on liver. Liver spot is 2mm, lung spots range from 2mm to 4mm. We don't know if they are cancer or not.
12/15/10: Brain MRI clear
1/7/11: PET/CT
1/13/11: Recurrence in lungs. Start Tykerb
5/13/11: Progression in lungs
6/3/11: Lung surgery to get tumors for chemosensitivity testing.
|
Threaded Mode